Jasper Ridge Partners, L.P. Oric Pharmaceuticals, Inc. Transaction History
Jasper Ridge Partners, L.P.
- $3.1 Billion
- Q1 2025
A detailed history of Jasper Ridge Partners, L.P. transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Jasper Ridge Partners, L.P. holds 20,870 shares of ORIC stock, worth $204,526. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20,870
Previous 20,870
-0.0%
Holding current value
$204,526
Previous $168,000
30.95%
% of portfolio
0.0%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding ORIC
# of Institutions
144Shares Held
75.9MCall Options Held
11.3KPut Options Held
2.7K-
Viking Global Investors LP6.57MShares$64.4 Million0.12% of portfolio
-
Nextech Invest Ag5.29MShares$51.8 Million7.95% of portfolio
-
Nextech Invest, Ltd. Zurich, V85.29MShares$51.8 Million6.85% of portfolio
-
Black Rock Inc. New York, NY4.83MShares$47.3 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY4MShares$39.2 Million0.05% of portfolio
About Oric Pharmaceuticals, Inc.
- Ticker ORIC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,576,700
- Market Cap $388M
- Description
- ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...